|
11 Jan 2010 |
Trubion Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (RA)
|
|
11 Jan 2010 |
Symphogen Publishes Pre-Clinical Data in Cancer Research Demonstrating Superior Efficacy of Anti-EGFR Monoclonal Antibody Combination Sym004
|
|
11 Jan 2010 |
AnaptysBio Announces Agreement with Roche to Develop Novel Antibodies
|
|
11 Jan 2010 |
Facet Biotech Announces Enrollment of First Patient in Phase 2 Study of Elotuzumab in Patients With Relapsed Multiple Myeloma
|
|
11 Jan 2010 |
Sorrento Therapeutics Announces Antibody Discovery and Development Alliance for the Prevention and Treatment of MRSA Infections
|
|
11 Jan 2010 |
ABLYNX SUCCESSFULLY GENERATES NANOBODIES AGAINST AN ION CHANNEL AND ANNOUNCES NEW GPCR PROGRAMME
|
|
11 Jan 2010 |
Sanofi Pasteur Partners with KaloBios on Novel Biologic for the Prevention and Treatment of Pseudomonas aeruginosa Infections
|
|
07 Jan 2010 |
Pfizer and Debiopharm collaborate to co-develop investigational compound tremelimumab (CP-675,206) in advanced melanoma
|
|
07 Jan 2010 |
Prolias Announces Strategic Technology Acquisition for Human Therapeutic Antibodies
|
|
07 Jan 2010 |
Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab
|
|
06 Jan 2010 |
InNexus Biotechnology Develops New Psoriasis Product Based on Its Skin Permeating Antibody Technology
|
|
04 Jan 2010 |
First Patient treated in BioInvent's Phase I Study of the Drug Candidate BI-505 to Treat Multiple Myeloma
|
|
04 Jan 2010 |
NeoPharm Announces IND Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
|
|
29 Dec 2009 |
Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility
|
|
24 Dec 2009 |
MedImmune Replies to FDA Complete Response Letter on Motavizumab
|
|
22 Dec 2009 |
PDL BioPharma Announces New Licensing Agreement With Eli Lilly
|
|
22 Dec 2009 |
ABLYNX DEMONSTRATES PROOF-OF-CONCEPT BY BIOMARKER FOR ITS ANTI-THROMBOTIC ALX-0081
|
|
22 Dec 2009 |
Genentech Submits Supplemental Application to FDA for Lucentis in Patients with Retinal Vein Occlusion
|
|
22 Dec 2009 |
to-BBB and Lundbeck to join forces on brain delivery of antibodies for CNS diseases
|
|
21 Dec 2009 |
UCB announces initial clinical trial results involving patients taking certolizumab pegol for moderate to severe Crohn's disease
|
|
21 Dec 2009 |
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with GlaxoSmithKline
|
|
18 Dec 2009 |
Amgen Receives CHMP Positive Opinion for Prolia(TM) (Denosumab) in the European Union
|
|
18 Dec 2009 |
Cangene receives a positive opinion from the European Medicines Agency ("EMA") for Hepatitis B product
|
|
18 Dec 2009 |
Thallion Announces Letter of Intent with LFB Biotechnologies to Develop and Commercialize Shigamabs®
|
|
18 Dec 2009 |
Herceptin receives positive opinion in record time for the treatment of HER2-positive advanced stomach cancer in Europe
|
